Pancreatic cancer models for translational research

D Behrens, W Walther, I Fichtner - Pharmacology & therapeutics, 2017 - Elsevier
Pancreatic cancer is a cruel, progressive disease that is highly metastatic and barely
treatable, a situation that is devastating for patients, family members, oncologists, clinicians …

Animal models: challenges and opportunities to determine optimal experimental models of pancreatitis and pancreatic cancer

JL Saloman, KM Albers, Z Cruz-Monserrate, BM Davis… - Pancreas, 2019 - journals.lww.com
At the 2018 PancreasFest meeting, experts participating in basic research met to discuss the
plethora of available animal models for studying exocrine pancreatic disease. In particular …

The advanced glycation end‐product Nϵ‐carboxymethyllysine promotes progression of pancreatic cancer: implications for diabetes‐associated risk and its …

S Menini, C Iacobini, L de Latouliere… - The Journal of …, 2018 - Wiley Online Library
Diabetes is an established risk factor for pancreatic cancer (PaC), together with obesity, a
Western diet, and tobacco smoking. The common mechanistic link might be the …

[HTML][HTML] Role of stromal activin A in human pancreatic cancer and metastasis in mice

G Mancinelli, C Torres, N Krett, J Bauer… - Scientific reports, 2021 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) has extensive stromal involvement and remains
one of the cancers with the highest mortality rates. Activin A has been implicated in colon …

[HTML][HTML] Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in KrasG12D/+ mice

S Menini, C Iacobini, L de Latouliere, I Manni… - Journal of Experimental …, 2020 - Springer
Background Type 1 and 2 diabetes confer an increased risk of pancreatic cancer (PaC) of
similar magnitude, suggesting a common mechanism. The recent finding that PaC incidence …

The RNA‐binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma

V Panzeri, I Manni, A Capone, C Naro… - Molecular …, 2021 - Wiley Online Library
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer. Most patients
present with advanced disease at diagnosis, which only permits palliative chemotherapeutic …

[HTML][HTML] Transgenic animal models to visualize cancer-related cellular processes by bioluminescence imaging

I Manni, L De Latouliere, A Gurtner… - Frontiers in …, 2019 - frontiersin.org
Preclinical animal models are valuable tools to improve treatments of malignant diseases,
being an intermediate step of experimentation between cell culture and human clinical trials …

Advancements in Preclinical Models of Pancreatic Cancer

P Salu, KM Reindl - Pancreas, 2024 - journals.lww.com
Pancreatic cancer remains one of the deadliest of all cancer types with a 5-year overall
survival rate of just 12%. Preclinical models available for understanding the disease …

Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasound

E Dugnani, V Pasquale, P Marra, D Liberati… - …, 2018 - academic.oup.com
Background The widely used genetically engineered mouse LSL-Kras G12D/+; LSL-Trp53
R172H/+; Pdx-1-Cre, termed KPC, spontaneously develops pancreatic cancer mirroring all …

[HTML][HTML] Development of two mouse strains conditionally expressing bright luciferases with distinct emission spectra as new tools for in vivo imaging

T Nakashiba, K Ogoh, S Iwano, T Sugiyama… - Lab Animal, 2023 - nature.com
In vivo bioluminescence imaging (BLI) has been an invaluable noninvasive method to
visualize molecular and cellular behaviors in laboratory animals. Bioluminescent reporter …